Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

NCT00191399 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression, Bipolar

Interventions

DRUG: Olanzapine
DRUG: Fluoxetine

Sponsor

Eli Lilly and Company